Related Experiment Video

Updated: Jul 15, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.2K

Post-COVID-19 syndrome in a cohort of hospitalized COVID-19 patients

Y Bildirici1, S Metintas, A Ucan

  • 1Department of Pediatrics, Eskisehir City Hospital, Eskisehir, Turkey. yasar.bildirici@saglik.gov.tr.

European Review for Medical and Pharmacological Sciences
|September 26, 2023
PubMed

Insights

Post-COVID-19 syndrome affects over half of hospitalized patients, with symptoms often persisting beyond the first month. Long-term monitoring is crucial for individuals experiencing severe COVID-19 and ongoing symptoms.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • COVID-19 can lead to prolonged health issues beyond the acute infection phase.
  • Post-COVID-19 syndrome presents a significant challenge for healthcare systems.
  • Understanding the long-term effects of COVID-19 is essential for patient management.

Purpose of the Study:

  • To determine the incidence of post-COVID-19 syndrome.
  • To identify factors associated with the development of post-COVID-19 syndrome.
  • To track the progression of post-COVID-19 syndrome symptoms over six months.

Main Methods:

  • A clinical cohort study was conducted.
  • Patients hospitalized with COVID-19 were evaluated at one, three, and six months post-discharge.
  • Standardized scales including mMRC Dyspnea Scale, CFS, MNA-SF, and MUST were used.

Main Results:

  • Post-COVID-19 syndrome was diagnosed in 57.5% of patients.
  • Symptoms initially increased, then decreased by the third month, stabilizing by the sixth.
  • Severe COVID-19 and early symptoms increased the risk of post-COVID-19 syndrome.

Conclusions:

  • COVID-19 has long-term implications, extending beyond the acute phase.
  • Patients with persistent symptoms after severe COVID-19 require extended follow-up.
  • Monitoring clinical outcomes is vital for managing long-term COVID-19 effects.
Abstract

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-1906:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.8K

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
314
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20